Mirum Pharmaceuticals (MIRM) Prepaid Assets (2018 - 2026)
Mirum Pharmaceuticals' quarterly Prepaid Assets came in at $24.5 million in Q1 2026, up 65.03% year-on-year from $14.9 million in Q1 2025, and up 35.31% quarter-over-quarter from $18.1 million in Q4 2025.
Mirum Pharmaceuticals has reported Prepaid Assets for 9 years, with the latest figure at $24.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 65.03% year-over-year to $24.5 million; the trailing twelve-month figure through Mar 2026 stood at $24.5 million (up 65.03% YoY), and the FY2025 full-year result was $18.1 million, up 53.94% from the prior year.
- Prepaid Assets for Q1 2026 stood at $24.5 million, up from $18.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $24.5 million in Q1 2026, with the low at $3.8 million in Q2 2022.
- Average Prepaid Assets over 5 years is $12.4 million, with a median of $10.9 million recorded in 2023.
- Year-over-year, Prepaid Assets fell 16.32% in 2022 and surged 157.52% in 2023.
- Tracing MIRM's Prepaid Assets over 5 years: stood at $8.9 million in 2022, then gained by 22.22% to $10.9 million in 2023, then grew by 7.76% to $11.8 million in 2024, then jumped by 53.94% to $18.1 million in 2025, then surged by 35.31% to $24.5 million in 2026.
- The last three Prepaid Assets figures came in at $24.5 million (Q1 2026), $18.1 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.55 Mn |
| Dec 31, 2025 | 18.14 Mn |
| Sep 30, 2025 | 23.87 Mn |
| Jun 30, 2025 | 19.07 Mn |
| Mar 31, 2025 | 14.87 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 8.59 Mn |
| Mar 31, 2024 | 10.02 Mn |
| Dec 31, 2023 | 10.94 Mn |
| Sep 30, 2023 | 12.47 Mn |
| Jun 30, 2023 | 9.73 Mn |
| Mar 31, 2023 | 8.99 Mn |
| Dec 31, 2022 | 8.95 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 4.52 Mn |
| Mar 31, 2021 | 4.64 Mn |
| Dec 31, 2020 | 4.53 Mn |
| Sep 30, 2020 | 4.40 Mn |
| Jun 30, 2020 | 2.74 Mn |
| Mar 31, 2020 | 2.91 Mn |
| Dec 31, 2019 | 2.70 Mn |
| Sep 30, 2019 | 3.06 Mn |
| Jun 30, 2019 | 666,000.00 |
| Dec 31, 2018 | 12,000.00 |